| Name | Title | Contact Details |
|---|
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
Nearly 133 million people in the U.S. have one or more chronic conditions—that`s almost half of all adults. UpWell Health strives to help this population feel normal by providing medications, products, services, information, and community support—all with a level of service and convenience rarely found in healthcare.
Center for Accredited Healthcare Education is a Raritan, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pittsburgh Benefits Group is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Microlife Usa is a Dunedin, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.